DOI QR코드

DOI QR Code

In vitro Cytotoxic Effect of Extracts from Styela plicata

오만둥이(Styela plicata) 추출물의 in vitro 세포독성 효과

  • Lee, Bo-Bae (Dept. of Food Science and Biotechnology, Kyungnam University) ;
  • Cha, Mi-Ran (Dept. of Food Science and Biotechnology, Kyungnam University) ;
  • Park, Hae-Ryong (Dept. of Food Science and Biotechnology, Kyungnam University) ;
  • Lee, Seung-Cheol (Dept. of Food Science and Biotechnology, Kyungnam University)
  • 이보배 (경남대학교 식품생명학과) ;
  • 차미란 (경남대학교 식품생명학과) ;
  • 박해룡 (경남대학교 식품생명학과) ;
  • 이승철 (경남대학교 식품생명학과)
  • Published : 2007.09.30

Abstract

The present study describes the preliminary evaluation of the anticancer activity of Styela plicata. Freeze-dried S. plicata was extracted with methanol, ethanol, acetone, and water, and then anticancer effect of the extracts was measured by the MTT reduction assay and phase-contrast microscopy on the HT-29 human colon carcinoma cells. Among the extracts, acetone extract showed the highest anticancer activity. The cell proliferation rates markedly decreased by 94.0% at the concentration of 500 ${\mu}g/mL$ of acetone extract compared with control cells. The acetone extract was further fractionated with hexane, diethyl ether, ethyl acetate, and water layer according to the degree of polarity. The HT-29 cells with hexane layer extract (250 ${\mu}g/mL$) decreased the cell viability to 5.1% of untreated control. The growth of SW620, HeLa, and MCF-7 cells was decreased to about 10%, by the treatment of hexane layer extract 250 ${\mu}g/mL$. Theses results suggest extracts from S. plicata as possible natural cancer therapeutic material.

오만둥이의 세포독성 효과를 알아보기 위해 신선한 오만둥이를 분쇄하고 동결건조하여 분말 형태로 제조한 후 시료 5 g당 메탄올, 에탄올, 아세톤, 물을 각각 100 mL씩 첨가하여 용매별 추출물을 제조하였다. 이 용매별 추출물을 대장암 세포주인 HT-29 cell에 250 ${\mu}g/mL$ 농도로 각각 처리하여 형태학적인 변화를 관찰한 결과 대조군에 비해 아세톤 추출물에서 세포의 수가 감소하고 그 형태가 응축되는 현상을 관찰할 수 있었고, 이 결과를 바탕으로 100, 250, 500 ${\mu}g/mL$ 농도로 MTT reduction assay를 실시한 결과 아세톤 추출물을 500 ${\mu}g/mL$ 농도로 처리했을 때 6%의 암세포만이 생존하는 것으로 나타나 형태학적인 실험결과와 동일한 결과를 얻을 수 있었다. 아세톤 추출물을 헥산, 디에틸 에테르, 에틸 아세테이트 그리고 물로 분획물을 조제하여 대장암 세포주인 HT-29 cell에 250 ${\mu}g/mL$ 농도로 각각 처리하여 형태학적인 변화를 관찰한 결과 헥산 분획물에서 세포의 형태변화가 가장 크게 나타났으며 250 ${\mu}g/mL$ 농도로 MTT reduction assay를 실시한 결과에서도 5.1%의 암세포만이 존재하는 것으로 나타나 헥산 분획물이 가장 높은 세포독성 효과를 보이는 것을 확인할 수 있었다. 다른 암세포주에 대한 영향을 알아보기 위해 헥산 분획물을 SW620, HeLa 및 MCF-7 세포주에 농도별로 처리한 결과, 250 ${\mu}g/mL$ 농도에서 10% 내외의 암세포 생존율을 보여 높은 세포독성 효과를 나타내었으며 특히, HeLa 세포주에서는 생존율이 5.8%로 나타나 매우 높은 활성을 보였다. 이상의 결과를 종합하여 미루어 짐작해 볼 때 오만둥이에 함유된 불포화 지방산 등의 지용성 물질이 암세포주의 성장 억제에 중요한 역할을 하리라 생각된다. 따라서 오만둥이 추출물은 다양한 암세포주에 대해 활성을 가지는 해양생물로서의 잠재적인 가능성을 가진다는 것을 확인할 수 있었다.

Keywords

References

  1. Im HG, Yu MH, Chung DW, Lee IS. 2006. Inhibitory effect of fungal metabolites isolated from foodstuffs on the growth of human cancer cell lines. Korean J Food Sci Technol 38: 262-267
  2. Shin YJ, Jung DY, Ha HK, Park SW. 2004. Anticancer effect of Erythronium japonicum extract on ICR mouse and L1210 cells with alteration of antioxidant enzyme activities. Korean J Food Sci Technol 36: 968-973
  3. Astrow AB. 1994. Rethinking cancer. Lancet 343: 494-503 https://doi.org/10.1016/S0140-6736(94)91454-0
  4. Bailer JC, Gormick HL. 1997. Cancer undefeated. N Eng J med 336: 1567-1575
  5. Garcia-Fernandez LF, Reyes F, Sanchez-Puelles JM. 2002. The marine pharmacy: new antitumoral compounds from the sea. Pharm News 9: 495-501 https://doi.org/10.1080/713743131
  6. Amador ML, Jimeno J, Paz-Ares L, Cortes-Funes H, Hidalgo M. 2003. Progress in the development and acquisition of anticancer agents from marine sources. Ann Oncol 14: 1607-1615 https://doi.org/10.1093/annonc/mdg443
  7. Lee EH, Chung SK, Jeon JK, Cha YJ, Chung SY. 1983. A study on the taste compounds of an ascidian, Styela plicata. Korean J Food Sci Technol 15: 1-5
  8. Tincu JA, Menzel LP, Azimov R, Sands J, Hong T, Waring AJ, Tayor SW, Lehrer RI. 2003. Plicatamide, an antimicrobial octapeptide from Styela plicata hemocyte. J Biol Chem 278: 13546-13553 https://doi.org/10.1074/jbc.M211332200
  9. Tincu JA, Taylor SW. 2004. Antimicrobial peptides from marine invertebrates. Antimicrob Agents Chemother 48: 3645-3654 https://doi.org/10.1128/AAC.48.10.3645-3654.2004
  10. Cardilo-Reis L, Cavalcante MC, Silveira CB, Pavao MS. 2006. In vivo antithrombotic properties of a heparin from the oocyte test cells of the sea squirt Styela plicata (Chordata-Tunicata). Braz J Med Biol Res 39: 1409-1415 https://doi.org/10.1590/S0100-879X2006001100004
  11. Cavalcante MC, Allodi S, Valente AP, Straus AH, Takahashi HK, Mourao PA, Pavao MS. 2000. Occurrence of heparin in the invertebrate Styela plicata (Tunicata) is restricted to cell layers facing the outside environment. J Biol Chem 275: 36189-36196 https://doi.org/10.1074/jbc.M005830200
  12. Wang R, Duan WJ, Zhang X, Zeng FL, Wan XX. 2006. Antiviral treatment of hepatitis B virus-transgenic mice by a marine organism, Styela plicata. World J Gastroenterol 12: 4038-4043 https://doi.org/10.3748/wjg.v12.i25.4038
  13. Kim JJ, Kim SJ, Kim SH, Park HR, Lee SC. 2005. Antioxidnat and anticancer activities of extracts from Styela plicata. J Korean Soc Food Sci Nutr 34: 937-941 https://doi.org/10.3746/jkfn.2005.34.7.937
  14. Mayer AM, Custafson KR. 2003. Marine pharmacology in 2000: antitumor and cytotoxic compounds. Int J Cancer 105: 291-299 https://doi.org/10.1002/ijc.11080
  15. Jimeno J, Faircloth G, Sousa-Faro JMF, Scheuer P, Rinehart K. 2004. New marine derived anticancer therapeutics - a journey from the sea to clinical trials. Mar Drugs 2: 14-29 https://doi.org/10.3390/md201014
  16. Fish B. 1984. Clinical trials for the evaluation of cancer therapy. Cancer Res 54: 609-615
  17. Goodman GY, Yen YP, Cox TC, Crowlny J. 1987. Effect of verapamil on in vitro cytotoxicity of adriamycin and vinblastine in human tumor cells. Cancer Res 47: 2295-2311
  18. SAS Institute. 1995. SAS/STAT User's Guide. SAS Institute Inc., Cary, NC, USA
  19. Raftos DA, Hutchinson A. 1995. Cytotoxicity reactions in the solitary tunicate Styela plicata. Dev Comp Immunol 19: 463-471 https://doi.org/10.1016/0145-305X(95)00028-R
  20. Cammarata M, Arizza V, Parrinello N, Candore G, Caruso C. 1997. Phenoloxidase-dependent cytotoxic mechanism in ascidian (Styela plicata) hemocytes active against erythrocytes and K562 tumor cells. Eur J Cell Biol 74: 302-307
  21. Lee EH, Oh KS, Lee TH, Ahn CB, Chung YH, Kim KS. 1985. Lipid components of sea squirt, Halocynthia roretzi, and mideuduck, Styela clava. Korean J Food Sci Technol 17: 289-294
  22. Siddiqui RA, Zerouga M, Wu M, Castillo A, Harvey K, Zaloga GP, Stillwell W. 2005. Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells. Breast Cancer Res 7: 645-654 https://doi.org/10.1186/bcr1036.
  23. Palakurthi SS, Fluckiger R, Aktas H, Changolkar AK, Shahdafaei A, Harneit S, Kilic E, Halperin JA. 2000. Inhibition of translation initiation mediates the anticancer effect of the n-3 polyunsaturated fatty acid eicosapentaenoic acid. Cancer Res 60: 2919-2925
  24. Chi TY, Chen GG, Lai PB. 2004. Eicosapentaenoic acid induces Fas-mediated apoptosis through a p53-dependent pathway in hepatoma cells. Cancer J 10: 190-200 https://doi.org/10.1097/00130404-200405000-00009

Cited by

  1. Antioxidant and Antihypertensive Activities of Styela plicata according to Harvesting Time and Size vol.40, pp.3, 2011, https://doi.org/10.3746/jkfn.2011.40.3.350